A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00311389 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-angle
Ocular Hypertension

Interventions

DRUG: Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution
DRUG: Latanoprost 0.005%/Timolol 0.005% ophthalmic solution

Sponsor

Alcon Research